ADAM Metallopeptidase Domain 10 (ADAM10) Antibody

Este producto es parte de ADAM10 - ADAM metallopeptidase domain 10
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
ADAM Metallopeptidase Domain 10 (ADAM10) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx301124
tested applications
ELISA, IHC, IF/ICC

Description

ADAM10 Antibody is a Rabbit Polyclonal against ADAM10.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
ADAM Metallopeptidase Domain 10 (ADAM10)
Host
Rabbit
Reactivity
Human
Recommended Dilution
IHC: 1/20 - 1/200, IF/ICC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA, IHC, IF/ICC
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
O14672
Gene ID
102
NCBI Accession
NP_001101.1, NM_001110.3
OMIM
602192
Alias
MADM, HsT18717,Kuz ,CD156d,AD10,AD18,RAK,KUZ,ADAM-10
Background
Antibody anti-ADAM10
Status
RUO

Descripción

ADAM10, also known as ADAM metallopeptidase domain 10, is a type I transmembrane glycoprotein belonging to the ADAM (a disintegrin and metalloproteinase) family of proteins. It is encoded by the ADAM10 gene located on human chromosome 15. ADAM10 plays crucial roles in various biological processes, including cell adhesion, cell fusion, cell signaling, proteolysis, and ectodomain shedding of membrane proteins. It is involved in the cleavage of a wide range of cell surface proteins, including cytokines, growth factors, adhesion molecules, and receptors. ( Notch receptors, amyloid precursor protein (APP), cadherins, and several cytokines and growth factors). The proteolytic activity of ADAM10 is tightly regulated, as its dysregulation can have significant implications in various diseases, including cancer, Alzheimer's disease, inflammation, and cardiovascular diseases. ADAM10-mediated cleavage of Notch receptors is crucial for various developmental processes, and dysregulation of this process has been implicated in cancer and neurodegenerative diseases. ADAM10 has gained significant attention as a potential therapeutic target for various diseases due to its involvement in critical cellular processes and its ability to modulate the activity of numerous substrates. Inhibition or modulation of ADAM10 activity is being explored as a strategy for the treatment of diseases such as cancer, Alzheimer's disease, and inflammatory disorders

Related Products

EH1041

Human ADAM10(Disintegrin and metalloproteinase domain-containing protein 10) ELISA Kit

Ver Producto
EM1631

Mouse ADAM10(Disintegrin and metalloproteinase domain-containing protein 10) ELISA Kit

Ver Producto
P8319

Recombinant Human ADAM10

Ver Producto